(R)-[N-3-[3-fluoro-4-[N-1-(4-carbobenzoxy)piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]methanol | 174649-04-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: (R)-[N-3-[3-fluoro-4-[N-1-(4-carbobenzoxy)piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]methanol
• 英文别名: (R)-[N3-[3-fluoro-4-[4-carbobenzoxypiperazin-1-yl]phenyl]-2-oxo-5-oxazolidinyl]methanol；(R)-benzyl 4-(2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenyl)piperazine-1-carboxylate；benzyl 4-[2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperazine-1-carboxylate
• CAS: 174649-04-8
• 化学式: C₂₂H₂₄FN₃O₅
• 分子量: 429.448
• InChiKey: UAQQNGDRKHDFAO-GOSISDBHSA-N

物化性质

• 熔点：
  155-157 °C
• 沸点：
  621.9±55.0 °C(Predicted)
• 密度：
  1.359±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  31
• 可旋转键数：
  6
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  82.6
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  (R)-[N-3-[3-fluoro-4-[N-1-(4-carbobenzoxy)piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]methanol 在 palladium on activated charcoal 吡啶 、 二氯甲烷 、 氢气 、 三乙胺 、 甲胺 作用下， 以 甲醇 、 乙醇 、 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 62.0h， 生成 N-[[(5S)-3-[3-氟-4-[4-(2-羟基乙酰基)-1-哌嗪基]苯基]-2-氧代-5-噁唑烷基]甲基]-乙酰胺
  参考文献：
  名称：

  Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections

  摘要：

  Bacterial resistance development has become a very serious clinical problem for many classes of antibiotics. The 3-aryl-2-oxazolidinones are a relatively new class of synthetic antibacterial agents, having a new mechanism of action which involves very early inhibition of bacterial protein synthesis. We have prepared two potent, synthetic oxazolidinones, U-100592 and U-100766, which are currently in clinical development for the treatment of serious multidrug-resistant Gram-positive bacterial infections caused by strains of staphylococci, streptococci, and enterococci. The in vitro and in vivo (po and iv) activities of U-100592 and U-100766 against representative strains are similar to those of vancomycin. U-100592 and U-100766 demonstrate potent in vitro activity against Mycobacterium tuberculosis. A novel and practical asymmetric synthesis of (5S)-(acetamidomethyl)-2-oxazolidinones has been developed and is employed for the synthesis of U-100592 and U-100766. This involves the reaction of N-lithioarylcarbamates with (R)-glycidyl butyrate, resulting in excellent yields and high enantiomeric purity of the intermediate (R)-5-(hydroxymethyl)-2-oxazolidinones,

  DOI：

  10.1021/jm9509556
• 作为产物：
  描述：

  N-[[(5S)-3-[3-氟-4-[4-(2-羟基乙酰基)-1-哌嗪基]苯基]-2-氧代-5-噁唑烷基]甲基]-乙酰胺 在 草酰氯 、 sodium hydride 、 碳酸氢钠 、 sodium carbonate 、 二甲基亚砜 、 三乙胺 、 亚硝基苯 、 D-脯氨酸 、 sodium iodide 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 、 丙酮 、 乙腈 为溶剂， 反应 24.0h， 生成 (R)-[N-3-[3-fluoro-4-[N-1-(4-carbobenzoxy)piperazinyl]-phenyl]-2-oxo-5-oxazolidinyl]methanol
  参考文献：
  名称：

  Short and practical enantioselective synthesis of linezolid and eperezolid via proline-catalyzed asymmetric α-aminooxylation

  摘要：

  An efficient enantioselective synthesis of the antibacterials, linezolid (U-100766), and eperezolid (U-100592) using D-proline-catalyzed asymmetric alpha-aminooxylation of aldehydes as the key step is described here. This is the first report on the enantioselective synthesis of linezolid and eperezolid using asymmetric catalysis. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2006.07.065

文献信息

• Oxazolidinone antibacterial agents having a thiocarbonyl functionality
  申请人：Pharmacia and Upjohn Company

  公开号：US06342513B1

  公开（公告）日：2002-01-29

  The present invention provides compounds of Formula 1: or pharmaceutical acceptable salts thereof wherein A, G and R1 are as defined in the claims which are antibacterial agents.

  本发明提供了式1化合物： 或药物可接受的盐，其中A，G和R1如权利要求中所定义，它们是抗菌剂。
• [EN] BORON CONTAINING SMALL MOLECULES<br/>[FR] PETITES MOLÉCULES CONTENANT DU BORE
  申请人：ANACOR PHARMACEUTICALS INC

  公开号：WO2011037731A1

  公开（公告）日：2011-03-31

  This invention provides, among other things, novel compounds useful for treating bacterial infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent.

  这项发明提供了用于治疗细菌感染的新化合物，包含这些化合物的药物组合物，以及这些化合物与至少一种其他治疗有效剂的组合。
• A short synthesis of oxazolidinone derivatives linezolid and eperezolid: A new class of antibacterials
  作者：Braj B. Lohray、Sundarababu Baskaran、B. Srinivasa Rao、B. Yadi Reddy、I. Nageswara Rao

  DOI：10.1016/s0040-4039(99)00893-x

  日期：1999.6

  Oxazolidinone derivatives such as Linezolid and Eperazolid, which are a new class of antibacterials, have been synthesized from 1,2,5,6-dianhydro-3,4-isopropylidine-D-mannitol in good yield.

  由1,2,5,6-二脱水-3,4-异丙基吡啶-D-甘露糖醇合成的新型抗菌剂恶唑烷酮衍生物（如Linezolid和Eperazolid）是高收率的。
• [EN] DRUGS CONJUGATED WITH HEXOSE PHOSPHATE AND METHODS OF MAKING AND USING SAME<br/>[FR] MÉDICAMENTS CONJUGUÉS À DU PHOSPHATE D'HEXOSE ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
  申请人：PARK JOO YOUN

  公开号：WO2022072425A1

  公开（公告）日：2022-04-07

  A drug conjugate, composition, and method for delivering active antimicrobials based on existing antibiotics through a hexose phosphate transporter (UhpT) by conjugating the antimicrobials with non-metabolizable hexose phosphates. Methods of co-administering antibiotics with non-metabolizable hexose phosphates as antimicrobials are also disclosed. Non-metabolizable hexose phosphates can constitutively and strongly induce expression of UhpT which significantly improves the efficacy and/or antimicrobial spectrum of antibiotics. This drug conjugate, composition and method will permit reuse of many FDA approved antibiotics that have been abandoned or fallen into disuse due to their current low efficacy and/or resistance to these antibiotics by pathogens.

  一种药物结合物、组合物和方法，通过将抗微生物药物与非代谢六糖磷酸酯结合，通过六糖磷酸转运体（UhpT）传递活性抗微生物药物，基于现有抗生素。还公开了联合给予抗生素和非代谢六糖磷酸酯作为抗微生物药物的方法。非代谢六糖磷酸酯可以构成性地和强烈地诱导UhpT的表达，从而显著提高抗生素的功效和/或抗微生物谱。这种药物结合物、组合物和方法将允许重复使用许多已被FDA批准但由于当前低功效和/或病原体对这些抗生素的抗药性而被放弃或停用的抗生素。
• A convenient synthesis of oxazolidinone derivatives linezolid and eperezolid from (S)-glyceraldehyde acetonide
  作者：Guangyu Xu、Yi Zhou、Chunhao Yang、Yuyuan Xie

  DOI：10.1002/hc.20435

  日期：2008.4

  A new convenient method for the synthesis of oxazolidinone antibacterials Linezolid and Eperezolid from readily available (S)-glyceraldehyde acetonide was developed. The key steps include reductive amination of arylamine and (S)-glyceraldehyde acetonide in the presence of NaBH4 and 4 A sieve, followed by hydrolysis and regioselective cyclization. © 2008 Wiley Periodicals, Inc. Heteroatom Chem 19:316–319

  开发了一种从容易获得的 (S)-甘油醛丙酮合成恶唑烷酮类抗菌剂利奈唑胺和依哌唑胺的新方法。关键步骤包括在 NaBH4 和 4A 筛存在下芳胺和 (S)-甘油醛缩​​醛的还原胺化，然后是水解和区域选择性环化。© 2008 Wiley Periodicals, Inc. 杂原子化学 19:316–319, 2008; 在线发表于 Wiley InterScience (www.interscience.wiley.com)。DOI 10.1002/hc.20435